Medical device developer Teleflex has received U.S. Food and Drug Administration 510(k) clearance for MR-conditional labeling on its Arrow EZ-IO intraosseous needle.
The needle is a critical component of the Arrow EZ-IO intraosseous vascular system, which can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, according to the vendor. With the new MR-conditional labeling, clinicians can now continuously care for patients who require MRI scans without interruption to the established site for vascular access, Teleflex said.
